CD274 and cancer: Use cases include immunohistochemical Ki-67 evaluation to determine a tumor’s proliferation rate [23], challenging to quantify biomarkers (e.g., immunohistochemical PD-L1 staining [24,25]), evaluation of residual cancer burden after chemotherapy [26], or cancer detection and classification algorithms (e.g., in prostate cancer [27,28,29]).